Glaxo Smith Klein – Patient Worthy

Breakthrough in COPD Management: GSK’s Nucala Advances Toward European Approval for Eosinophilic Patients

Post author:Bree Clare
Post published:December 22, 2025
Post category:Chronic obstructive pulmonary disease (COPD)

GSK announced a significant milestone in respiratory medicine as the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Nucala (mepolizumab) for treating uncontrolled…

CLICK HERE TO SHARE YOUR STORY!

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More